Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Uwe Platzbecker

1-50 of 370 results

View this query on the Wikidata Query Service
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

scientific article
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia

scientific article
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

scientific article published on 26 August 2013
Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation fo

scientific article published on 11 April 2011
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q

scientific article published on 13 July 2011
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial.

scientific article published on 2 September 2011
Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit

scientific article published on 3 April 2014
P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate

scientific article
Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium

scientific article published on 29 September 2008
Clonal architecture of chronic myelomonocytic leukemias

scientific article published on 14 January 2013
A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy

scientific article published on November 4, 2011
Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation

scientific article published on January 14, 2013
Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

scientific article
A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial

scientific article published on 4 May 2010
Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome

scientific article published on 8 August 2012
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial

scientific article published on 31 October 2016
Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.

scientific article
Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9

scientific article published on 15 February 2016
WNT5A is induced by inflammatory mediators in bone marrow stromal cells and regulates cytokine and chemokine production

scientific article
Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom).

scientific article
Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS)

scientific article
The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML.

scientific article published on 8 May 2013
Cancer‐testis antigen expression and its epigenetic modulation in acute myeloid leukemia

scientific article published on September 2, 2011
Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease

scientific article published on 06 January 2015
Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study

scientific article published on September 2017
Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents

scientific article
Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia

scientific article
Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study Gro

scientific article published on 23 December 2014
Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity

scientific article published on 13 June 2016
5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis

scientific article published on 12 October 2009
Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial

scientific article
Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation

scientific article published on November 2009
SETBP1 mutation analysis in 944 patients with MDS and AML.

scientific article published on 7 May 2013
Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs

scientific article published on 01 February 2001
Mesenchymal stromal cells from patients with myelodyplastic syndrome display distinct functional alterations that are modulated by lenalidomide

scientific article published on 28 May 2013
Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter study.

scientific article published on 13 January 2012
18F-FDG-PET/CT for detection of extramedullary acute myeloid leukemia

scientific article published on June 17, 2011
Mutational hierarchies in myelodysplastic syndromes dynamically adapt and evolve upon therapy response and failure

scientific article
Myelodysplasia is in the niche: novel concepts and emerging therapies

scientific article
Iron overload in allogeneic hematopoietic cell transplantation outcome: a meta-analysis

scientific article
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group

scientific article published on 14 September 2012
Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome

scientific article
Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin

scientific article published on 01 July 2000
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet

scholarly article by Miguel A Sanz et al published 11 April 2019 in Blood
Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload

scientific article published on October 17, 2012
Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry.

scientific article published on 5 March 2016
Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study

scientific article published on 28 January 2013
Allogeneic hematopoietic cell transplantation in patients age 60-70 years with de novo high-risk myelodysplastic syndrome or secondary acute myelogenous leukemia: comparison with patients lacking donors who received azacitidine

scientific article
Minimal residual disease-directed preemptive treatment with azacitidine in patients with NPM1-mutant acute myeloid leukemia and molecular relapse

scientific article published on 12 July 2011
Validation of the revised international prognostic scoring system (IPSS-R) in patients with myelodysplastic syndrome: a multicenter study

scientific article

Paulina is supported by:

About Paulina

Help